These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 26788615)

  • 1. Idiopathic pulmonary fibrosis: the role of pathobiology in making a definitive diagnosis.
    Padilla M
    Am J Manag Care; 2015 Oct; 21(14 Suppl):s276-83. PubMed ID: 26788615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic pulmonary fibrosis: the turning point is now!
    Funke M; Geiser T
    Swiss Med Wkly; 2015; 145():w14139. PubMed ID: 26024356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosis.
    Aiello M; Bertorelli G; Bocchino M; Chetta A; Fiore-Donati A; Fois A; Marinari S; Oggionni T; Polla B; Rosi E; Stanziola A; Varone F; Sanduzzi A
    Pulm Pharmacol Ther; 2017 Jun; 44():7-15. PubMed ID: 28257817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib.
    Bonella F; Stowasser S; Wollin L
    Drug Des Devel Ther; 2015; 9():6407-19. PubMed ID: 26715838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape.
    Glassberg MK
    Am J Manag Care; 2019 Jul; 25(11 Suppl):S195-S203. PubMed ID: 31419091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines.
    Sharif R
    Am J Manag Care; 2017 Jul; 23(11 Suppl):S176-S182. PubMed ID: 28978212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective.
    Moodley Y; Corte T; Richeldi L; King TE
    Respirology; 2015 Apr; 20(3):389-94. PubMed ID: 25727967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations.
    Jo HE; Randhawa S; Corte TJ; Moodley Y
    Drugs Aging; 2016 May; 33(5):321-34. PubMed ID: 27083934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer in patients with idiopathic pulmonary fibrosis.
    Karampitsakos T; Tzilas V; Tringidou R; Steiropoulos P; Aidinis V; Papiris SA; Bouros D; Tzouvelekis A
    Pulm Pharmacol Ther; 2017 Aug; 45():1-10. PubMed ID: 28377145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic pulmonary fibrosis: pathogenesis and management.
    Sgalla G; Iovene B; Calvello M; Ori M; Varone F; Richeldi L
    Respir Res; 2018 Feb; 19(1):32. PubMed ID: 29471816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Idiopathic pulmonary fibrosis: modern guideline-concordant diagnostics and innovative treatment].
    Behr J
    Dtsch Med Wochenschr; 2012 Mar; 137(12):601-4. PubMed ID: 22415624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic pulmonary fibrosis: evolving concepts.
    Ryu JH; Moua T; Daniels CE; Hartman TE; Yi ES; Utz JP; Limper AH
    Mayo Clin Proc; 2014 Aug; 89(8):1130-42. PubMed ID: 24867394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Idiopathic Pulmonary Fibrosis].
    Prasse A
    Pneumologie; 2015 Oct; 69(10):608-14; quiz 615. PubMed ID: 26444136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Idiopathic pulmonary fibrosis: recent diagnostic and therapeutic advances].
    Petitpierre N; Beigelman C; Letovanec I; Nicod LP; Lazor R
    Rev Med Suisse; 2014 Nov; 10(451):2208-10, 2212-3. PubMed ID: 25603568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy.
    Spagnolo P; Maher TM; Richeldi L
    Pharmacol Ther; 2015 Aug; 152():18-27. PubMed ID: 25946646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications.
    Nair GB; Matela A; Kurbanov D; Raghu G
    Expert Rev Respir Med; 2016 Jun; 10(6):699-711. PubMed ID: 27094006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical management of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):90-8. PubMed ID: 26278687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating Idiopathic pulmonary fibrosis guidelines into clinical practice.
    Robalo-Cordeiro C; Morais A
    Pulmonology; 2021; 27(1):7-13. PubMed ID: 32561352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Idiopathic Pulmonary Fibrosis in the Elderly Patient: Addressing Key Questions.
    Meyer KC; Danoff SK; Lancaster LH; Nathan SD
    Chest; 2015 Jul; 148(1):242-252. PubMed ID: 26149553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel agents for idiopathic pulmonary fibrosis: progress in target selection and clinical trial design.
    O'Riordan TG; Smith V; Raghu G
    Chest; 2015 Oct; 148(4):1083-1092. PubMed ID: 26020856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.